Which class of drugs includes SGLT2 inhibitors?

SGLT2 inhibitors belong to the class of diabetes medications specifically designed to help manage blood glucose levels in individuals with type 2 diabetes. These drugs work by blocking the sodium-glucose co-transporter 2 in the kidneys, which results in the excretion of glucose in the urine and lowers blood sugar levels. This mechanism directly targets the pathology of diabetes, making these medications an essential part of diabetes management.

While diuretics, antidepressants, and antihypertensives serve important roles in treating other health conditions, they do not have the specific action of lowering blood sugar levels or addressing the underlying issues associated with diabetes. Therefore, identifying SGLT2 inhibitors as diabetes medications is particularly accurate, as it highlights their primary function and therapeutic role in the management of diabetes.